Associate professor, Department of Pharmacology
office: bldg. A16/125
Kamenice 753/5
625 00 Brno
| phone: | +420 549 49 3971 |
|---|---|
| e‑mail: |
|
| social and academic networks: |
|---|
| Habilitation procedures | |
|---|---|
| Applicant's name at procedure initiation | PharmDr. Ondřej Zendulka, Ph.D. |
| Applicant's workplace at procedure initiation | Faculty of Medicine |
| Procedure field | Pharmacology |
| Faculty implementing procedure | Faculty of Medicine |
| Procedure status | appointment to associate professor |
| Procedure initiation date | 13 Dec 2018 |
| Procedure conclusion date | 1 Jul 2020 |
| Habilitation thesis (publicly available part) | The role of cytochrome P450 in drug safety and efficacy |
| Habilitation thesis reviewers |
prof. MUDr. Stanislav Mičuda, Ph.D. (Ústav farmakologie LF UK)
prof. Wladyslawa Daniel, PhD (Maj Institute of Pharmacology) prof. PharmDr. Ján Klimas, PhD. (Farmaceutická fakulta UK Bratislava, SR) |
| Reviewers' thesis reports | Report 1 | Report 2 | Report 3 |
| Public lecture | 21 Jun 2019 | Lecture Evaluation |
| habilitation board | |
| Chair | prof. PharmDr. Petr Babula, Ph.D. (Faculty of Medicine MU) |
| Members |
doc. MUDr. Regina Demlová, Ph.D.
(Faculty of Medicine MU)
prof. PharmDr. Daniela Ježová, DrSc. (Ústav experimentálnej endokrinológie SAV) prof. RNDr. Pavel Anzenbacher, DrSc. (Lékařská fakulta UP Olomouc) prof. Dr. Julia Carolin Stingl (- Federal Institute for Drugs and Medical Devices, University Bonn Medical School) |
| Board decision | Board Decision |
| Faculty scientific board session date | 28 May 2020 |